View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
MONDAY, July 20 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved an influenza vaccine for the 2009-2010 season, according to a news release issued July 20 by the FDA.
The vaccine will not protect against the H1N1 flu virus, which led to a World Health Organization pandemic declaration this year. However, efforts to develop an H1N1 vaccine are under way. The 2009-2010 seasonal flu vaccine will contain an A/Brisbane/59/2007 (H1N1)-like virus, an A/Brisbane/10/2007 (H3N2)-like virus, and a B/Brisbane/60/2008-like virus.
The FDA cautions that no vaccine is 100 percent effective, but stresses that vaccination is the best protection against the flu and that high-risk Americans should be vaccinated. Young children, elderly people, and those with chronic medical conditions are at high risk, and it is critical that they be vaccinated.
"The approval of this year's seasonal influenza vaccine is an example of the FDA's important responsibility to assure timely availability of vaccine to help protect the health of the American public," Margaret A. Hamburg, M.D., commissioner of food and drugs at the FDA in Silver Spring, Md., said in a statement. "A new seasonal influenza vaccine each year is a critical tool in protecting public health."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top